{
    "@context": "https://api.researchmap.jp/researcher.jsonld",
    "@id": "https://api.researchmap.jp/1619?format=json",
    "@type": "researchers",
    "rm:user_id": "0000041130",
    "rm:creator_id": "0000041130",
    "rm:creator_type": "myself",
    "rm:created": "2002-10-29T15:00:00Z",
    "rm:modifier_id": "0000041130",
    "rm:modifier_type": "myself",
    "rm:modified": "2024-10-12T02:11:31Z",
    "permalink": "1619",
    "family_name": {
        "ja": "早川",
        "ja-Kana": "ハヤカワ",
        "en": "Hayakawa"
    },
    "given_name": {
        "ja": "堯夫",
        "ja-Kana": "タカオ",
        "en": "Takao"
    },
    "display_name_kana": "disclosed",
    "display_nickname": "disclosed",
    "display_image": "disclosed",
    "display_contact_point": "disclosed",
    "affiliations": [
        {
            "affiliation": {
                "ja": "近畿大学",
                "en": "Kindai University"
            },
            "section": {
                "ja": "薬学総合研究所",
                "en": "Pharmaceutical Research and Technology Institute"
            },
            "display_affiliation": "disclosed",
            "display_job": "disclosed",
            "rm:institution_code": "2617025000"
        }
    ],
    "degrees": [
        {
            "degree": {
                "ja": "薬学博士"
            },
            "display_degree": "disclosed",
            "rm:institution_code": "9999999999"
        }
    ],
    "display_profile": "disclosed",
    "display_url": "disclosed",
    "identifiers": {
        "j_global_id": [
            "200901068512296493"
        ]
    },
    "rm:erad_id_verified": false,
    "rm:orc_id_verified": false,
    "display_erad_id": "researchers_only",
    "display_orc_id": "closed",
    "display_researcher_id": "disclosed",
    "display_j_global_id": "disclosed",
    "see_also": [
        {
            "label": "j_global",
            "@id": "https://jglobal.jst.go.jp/detail?JGLOBAL_ID=200901068512296493"
        }
    ],
    "@graph": [
        {
            "@id": "https://api.researchmap.jp/1619/research_areas",
            "@type": "research_areas",
            "@reverse": "https://api.researchmap.jp/1619",
            "total_items": 1,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/1619/research_areas/44496222",
                    "@type": "research_areas",
                    "@reverse": "https://api.researchmap.jp/1619/research_areas",
                    "rm:id": "44496222",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2024-01-22T17:44:59Z",
                    "rm:modifier_id": "0000041130",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2024-01-22T17:44:59Z",
                    "discipline_number": "A189",
                    "item_number": "A38030",
                    "discipline": {
                        "ja": "ライフサイエンス",
                        "en": "Life sciences"
                    },
                    "research_field": {
                        "ja": "応用生物化学",
                        "en": "Applied biochemistry"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/1619/research_experience",
            "@type": "research_experience",
            "@reverse": "https://api.researchmap.jp/1619",
            "total_items": 1,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/1619/research_experience/15779755",
                    "@type": "research_experience",
                    "@reverse": "https://api.researchmap.jp/1619/research_experience",
                    "rm:id": "15779755",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "client_id:2g~mXDjzLTpGal_I",
                    "rm:creator_type": "institution",
                    "rm:created": "2015-09-12T03:42:09Z",
                    "rm:modifier_id": "client_id:2g~mXDjzLTpGal_I",
                    "rm:modifier_type": "institution",
                    "rm:modified": "2015-09-12T03:42:09Z",
                    "rm:institution_code": "9999999999",
                    "affiliation": {
                        "ja": "旧所属 厚生労働省 国立医薬品食品衛生研究所 副所長",
                        "en": "Former Institution /Organization Deputy Director Geueral"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/1619/published_papers",
            "@type": "published_papers",
            "@reverse": "https://api.researchmap.jp/1619",
            "total_items": 4,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/1619/published_papers/47540484",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/1619/published_papers",
                    "rm:id": "47540484",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_internal_feeds",
                    "rm:creator_type": "ai",
                    "rm:created": "2024-08-28T02:04:38Z",
                    "rm:modifier_id": "ai:assign_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2024-08-28T02:04:38Z",
                    "paper_title": {
                        "en": "Erratum: Fiber-mutant technique can augment gene transduction efficacy and anti-tumor effects against established murine melanoma by cytokine-gene therapy using adenovirus vectors (Cancer Letters (2002) 177 (57-63))"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Yuka Okada"
                            },
                            {
                                "name": "Naoki Okada"
                            },
                            {
                                "name": "Shinsaku Nakagawa"
                            },
                            {
                                "name": "Hiroyuki Mizuguchi"
                            },
                            {
                                "name": "Makiko Kanehira"
                            },
                            {
                                "name": "Naoko Nishino"
                            },
                            {
                                "name": "Koichi Takahashi"
                            },
                            {
                                "name": "Nobuyasu Mizuno"
                            },
                            {
                                "name": "Takao Hayakawa"
                            },
                            {
                                "name": "Tadanori Mayumi"
                            }
                        ]
                    },
                    "publisher": {
                        "en": "Elsevier Ireland Ltd"
                    },
                    "publication_date": "2004-02-10",
                    "publication_name": {
                        "en": "Cancer Letters"
                    },
                    "volume": "204",
                    "number": "1",
                    "starting_page": "115",
                    "ending_page": "116",
                    "languages": [
                        "eng"
                    ],
                    "published_paper_type": "scientific_journal",
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/j.canlet.2003.08.009"
                        ],
                        "issn": [
                            "0304-3835"
                        ],
                        "scopus_id": [
                            "1642564266"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/j.canlet.2003.08.009",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/1619/published_papers/42791906",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/1619/published_papers",
                    "rm:id": "42791906",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_papers",
                    "rm:creator_type": "ai",
                    "rm:created": "2023-07-11T08:30:29Z",
                    "rm:modifier_id": "ai:assign_based_papers",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2023-07-11T08:30:29Z",
                    "paper_title": {
                        "ja": "平成12年度「日本薬局方の試験法に関する研究」研究報告 核酸増幅法によるウイルスゲノム等検出に関するフィージビリティスタディ"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "早川 尭夫"
                            },
                            {
                                "name": "山口 照英"
                            },
                            {
                                "name": "押澤 正"
                            },
                            {
                                "name": "石井 明子[渡部]"
                            }
                        ]
                    },
                    "publisher": {
                        "ja": "(一財)医薬品医療機器レギュラトリーサイエンス財団"
                    },
                    "publication_date": "2002-04",
                    "publication_name": {
                        "ja": "医薬品研究"
                    },
                    "volume": "33",
                    "number": "4",
                    "starting_page": "275",
                    "ending_page": "284",
                    "languages": [
                        "jpn"
                    ],
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0287-0894"
                        ],
                        "jamas_id": [
                            "2002167607"
                        ]
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/1619/published_papers/48184153",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/1619/published_papers",
                    "rm:id": "48184153",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_internal_feeds",
                    "rm:creator_type": "ai",
                    "rm:created": "2024-10-12T02:11:31Z",
                    "rm:modifier_id": "ai:assign_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2024-10-12T02:11:31Z",
                    "paper_title": {
                        "ja": "分化型HL-60細胞の活性酸素産生に対するオカダ酸の効果"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "鈴木 和博"
                            },
                            {
                                "name": "押澤 正"
                            },
                            {
                                "name": "山口 照英"
                            },
                            {
                                "name": "山本 行男"
                            },
                            {
                                "name": "田中 寿一"
                            },
                            {
                                "name": "早川 堯夫"
                            }
                        ]
                    },
                    "publisher": {
                        "ja": "(NPO)日本免疫学会"
                    },
                    "publication_date": "1993-10",
                    "publication_name": {
                        "ja": "日本免疫学会総会・学術集会記録"
                    },
                    "volume": "23",
                    "starting_page": "412",
                    "ending_page": "412",
                    "languages": [
                        "jpn"
                    ],
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0919-1984"
                        ],
                        "jamas_id": [
                            "2020368212"
                        ]
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/1619/published_papers/48184152",
                    "@type": "published_papers",
                    "@reverse": "https://api.researchmap.jp/1619/published_papers",
                    "rm:id": "48184152",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_internal_feeds",
                    "rm:creator_type": "ai",
                    "rm:created": "2024-10-12T02:11:31Z",
                    "rm:modifier_id": "ai:assign_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2024-10-12T02:11:31Z",
                    "paper_title": {
                        "ja": "HL-60細胞の分化誘導におけるG-CSFの影響について"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "山口 照英"
                            },
                            {
                                "name": "山口 高正"
                            },
                            {
                                "name": "押澤 正"
                            },
                            {
                                "name": "山本 行男"
                            },
                            {
                                "name": "鈴木 和博"
                            },
                            {
                                "name": "早川 堯夫"
                            }
                        ]
                    },
                    "publisher": {
                        "ja": "(NPO)日本免疫学会"
                    },
                    "publication_date": "1993-10",
                    "publication_name": {
                        "ja": "日本免疫学会総会・学術集会記録"
                    },
                    "volume": "23",
                    "starting_page": "413",
                    "ending_page": "413",
                    "languages": [
                        "jpn"
                    ],
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0919-1984"
                        ],
                        "jamas_id": [
                            "2020368214"
                        ]
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/1619/misc",
            "@type": "misc",
            "@reverse": "https://api.researchmap.jp/1619",
            "total_items": 125,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/1619/misc/45675709",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/1619/misc",
                    "rm:id": "45675709",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_papers",
                    "rm:creator_type": "ai",
                    "rm:created": "2024-02-28T13:50:01Z",
                    "rm:modifier_id": "ai:assign_based_papers",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2024-02-28T13:50:01Z",
                    "paper_title": {
                        "ja": "癌に対する抗血管新生療法の現状と展望(その2)"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "新見 伸吾"
                            },
                            {
                                "name": "原島 瑞"
                            },
                            {
                                "name": "日向 昌司"
                            },
                            {
                                "name": "山口 照英"
                            },
                            {
                                "name": "早川 堯夫"
                            }
                        ]
                    },
                    "publisher": {
                        "ja": "(一財)医薬品医療機器レギュラトリーサイエンス財団"
                    },
                    "publication_date": "2008-06",
                    "publication_name": {
                        "ja": "医薬品研究"
                    },
                    "volume": "39",
                    "number": "6",
                    "starting_page": "359",
                    "ending_page": "387",
                    "languages": [
                        "jpn"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0287-0894"
                        ],
                        "jamas_id": [
                            "2008241255"
                        ]
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/1619/misc/45675710",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/1619/misc",
                    "rm:id": "45675710",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_papers",
                    "rm:creator_type": "ai",
                    "rm:created": "2024-02-28T13:50:01Z",
                    "rm:modifier_id": "ai:assign_based_papers",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2024-02-28T13:50:01Z",
                    "paper_title": {
                        "ja": "癌に対する抗血管新生療法の現状と展望(その1)"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "新見 伸吾"
                            },
                            {
                                "name": "原島 瑞"
                            },
                            {
                                "name": "日向 昌司"
                            },
                            {
                                "name": "山口 照英"
                            },
                            {
                                "name": "早川 堯夫"
                            }
                        ]
                    },
                    "publisher": {
                        "ja": "(一財)医薬品医療機器レギュラトリーサイエンス財団"
                    },
                    "publication_date": "2008-01",
                    "publication_name": {
                        "ja": "医薬品研究"
                    },
                    "volume": "39",
                    "number": "1",
                    "starting_page": "1",
                    "ending_page": "37",
                    "languages": [
                        "jpn"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0287-0894"
                        ],
                        "jamas_id": [
                            "2008146782"
                        ]
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/1619/misc/45675966",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/1619/misc",
                    "rm:id": "45675966",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_papers",
                    "rm:creator_type": "ai",
                    "rm:created": "2024-02-28T15:29:21Z",
                    "rm:modifier_id": "ai:assign_based_papers",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2024-02-28T15:29:21Z",
                    "paper_title": {
                        "ja": "血管新生療法の現状と展望"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "新見 伸吾"
                            },
                            {
                                "name": "原島 瑞"
                            },
                            {
                                "name": "日向 昌司"
                            },
                            {
                                "name": "野間 誠司"
                            },
                            {
                                "name": "川西 徹"
                            },
                            {
                                "name": "早川 堯夫"
                            }
                        ]
                    },
                    "publisher": {
                        "ja": "(一財)医薬品医療機器レギュラトリーサイエンス財団"
                    },
                    "publication_date": "2006-10",
                    "publication_name": {
                        "ja": "医薬品研究"
                    },
                    "volume": "37",
                    "number": "10",
                    "starting_page": "641",
                    "ending_page": "670",
                    "languages": [
                        "jpn"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0287-0894"
                        ],
                        "jamas_id": [
                            "2007065562"
                        ]
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/1619/misc/45675967",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/1619/misc",
                    "rm:id": "45675967",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_papers",
                    "rm:creator_type": "ai",
                    "rm:created": "2024-02-28T15:29:22Z",
                    "rm:modifier_id": "ai:assign_based_papers",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2024-02-28T15:29:22Z",
                    "paper_title": {
                        "ja": "肝幹細胞に関する研究の現状と肝疾患の細胞治療への応用の展望"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "新見 伸吾"
                            },
                            {
                                "name": "原島 瑞"
                            },
                            {
                                "name": "日向 昌司"
                            },
                            {
                                "name": "野間 誠司"
                            },
                            {
                                "name": "川西 徹"
                            },
                            {
                                "name": "早川 尭夫"
                            }
                        ]
                    },
                    "publisher": {
                        "ja": "(一財)医薬品医療機器レギュラトリーサイエンス財団"
                    },
                    "publication_date": "2005-11",
                    "publication_name": {
                        "ja": "医薬品研究"
                    },
                    "volume": "36",
                    "number": "11",
                    "starting_page": "481",
                    "ending_page": "496",
                    "languages": [
                        "jpn"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0287-0894"
                        ],
                        "jamas_id": [
                            "2006046163"
                        ]
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/1619/misc/45675968",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/1619/misc",
                    "rm:id": "45675968",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_papers",
                    "rm:creator_type": "ai",
                    "rm:created": "2024-02-28T15:29:22Z",
                    "rm:modifier_id": "ai:assign_based_papers",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2024-02-28T15:29:22Z",
                    "paper_title": {
                        "ja": "糖鎖プロファイリングを用いた差異解析に基づくグライコーム解析法の開発"
                    },
                    "authors": {
                        "ja": [
                            {
                                "name": "橋井 則貴"
                            },
                            {
                                "name": "川崎 ナナ"
                            },
                            {
                                "name": "伊藤 さつき"
                            },
                            {
                                "name": "日向 昌司"
                            },
                            {
                                "name": "川西 徹"
                            },
                            {
                                "name": "早川 尭夫"
                            }
                        ]
                    },
                    "publisher": {
                        "ja": "(公社)日本薬学会"
                    },
                    "publication_date": "2004-03",
                    "publication_name": {
                        "ja": "日本薬学会年会要旨集"
                    },
                    "volume": "124年会",
                    "number": "3",
                    "starting_page": "80",
                    "ending_page": "80",
                    "languages": [
                        "jpn"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "issn": [
                            "0918-9823"
                        ],
                        "jamas_id": [
                            "2004142919"
                        ]
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/1619/misc/1906165",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/1619/misc",
                    "rm:id": "1906165",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2002-10-29T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-30T05:14:23Z",
                    "paper_title": {
                        "en": "Efficient gene transfer into human CD34(+) cells by an adenovirus type 35 vector"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "F Sakurai"
                            },
                            {
                                "name": "H Mizuguchi"
                            },
                            {
                                "name": "T Hayakawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "Efficient gene transfer into human hematopoietic stem cells (HSCs) is the most important requirement for gene therapy of hematopoietic disorders and for study of the hematopoietic system. An adenovirus (Ad) vector based on the Ad serotype 5 (Ad5) is known to transduce HSCs, including CD34(+) cells, with very low efficiency because of low-level expression of its primary receptor, coxsackievirus and adenovirus receptor (CAR). In the present study, we developed a recombinant Ad vector composed of the whole Ad serotype 35 (Ad35), which recognizes an unidentified receptor different from CAR for its infection. A transduction study showed that the Ad35-based vectors exhibit a higher transduction efficiency in human CD34(+) cells than the conventional Ad5 vectors and the Ad5F35 vectors, which are fiber-substituted Ad5 vectors containing Ad35 fiber proteins. The mean of fluorescence intensity in the CD34+ cells transduced with the Ad35 vectors was 12-76 and 1.4-3 times higher than that in the cells transduced with the Ad5 and Ad5F35 vectors, respectively. The percentages of green fluorescent protein (GFP)-positive CD34(+) cells by transduction with Ad35, Ad5, and Ad5F35 vectors expressing GFP at 300 PFU/cell were 53%, 5%, and 52%, respectively, suggesting that Ad35 vectors mediate a more efficient gene transfer into human CD34(+) cells than Ad5 and Ad5F35 vectors, although the percentage of transduced cells was similar between Ad35 and Ad5F35 vectors. The Ad vector based on Ad35 could be very useful in gene therapy for blood disorders and gene transfer experiments using HSCs. Gene Therapy (2003) 10, 1041-1048. doi: 10.1038/sj.gt.3301959."
                    },
                    "publisher": {
                        "en": "NATURE PUBLISHING GROUP"
                    },
                    "publication_date": "2003-06",
                    "publication_name": {
                        "en": "GENE THERAPY"
                    },
                    "volume": "10",
                    "number": "12",
                    "starting_page": "1041",
                    "ending_page": "1048",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1038/sj.gt.3301959"
                        ],
                        "issn": [
                            "0969-7128"
                        ],
                        "wos_id": [
                            "WOS:000183237200007"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1038/sj.gt.3301959",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000183237200007&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/1619/misc/1906154",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/1619/misc",
                    "rm:id": "1906154",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2002-10-29T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-08-28T15:36:30Z",
                    "paper_title": {
                        "en": "Structural analysis of a glycoprotein by liquid chromatography-mass spectrometry and liquid chromatography with tandem mass spectrometry - Application to recombinant human thrombomodulin"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Satsuki Itoh"
                            },
                            {
                                "name": "Nana Kawasaki"
                            },
                            {
                                "name": "Miyako Ohta"
                            },
                            {
                                "name": "Takao Hayakawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "Using recombinant human thrombomodulin (rhTM) expressed in Chinese hamster ovary (CHO) cells, we studied the structural analysis of a glycoprotein by liquid chromatography-mass spectrometry (LC-MS) and liquid chromatography with tandem mass spectrometry (LC-MS-MS). First, we analyzed the structure of both the O- and N-linked glycans in rhTM by oligosaccharide mapping using LC-MS equipped with a graphitized carbon column (GCC-LC-MS). Major O- and N-linked glycans were determined to be core 1 structure and fucosyl biantennary containing NeuAc0-2, respectively. Next, the post-translational modifications and their heterogeneities, including the site-specific glycosylation, were analyzed by mass spectrometric peptide/glycopeptide mapping of trypsin-digested rhTM and precursor-ion scanning. Precursor-ion scanning was successful in the detection of five glycopeptides. Four N-glycosylation sites and their site-specific carbohydrate heterogeneity were determined by their mass spectra. O-Glycosylation could be estimated on the basis of its mass spectrum. We were able to identify partial β-hydroxylation on Asn324 and Asn439, and O-linked glucose on Ser287 from the peptide/glycopeptide map and their mass spectra. We demonstrated that a sequential analysis of LC-MS and LC-MS-MS are very useful for the structural analysis of O- and N-linked glycans, polypeptides, and post-translational modifications and their heterogeneities, including site-specific glycosylation in a glycoprotein. Our method can be applied to a glycoprotein in biological samples. © 2002 Elsevier Science B.V. All rights reserved."
                    },
                    "publication_date": "2002-11-29",
                    "publication_name": {
                        "en": "Journal of Chromatography A"
                    },
                    "volume": "978",
                    "number": "1-2",
                    "starting_page": "141",
                    "ending_page": "152",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/S0021-9673(02)01423-1"
                        ],
                        "issn": [
                            "0021-9673"
                        ],
                        "pm_id": [
                            "12458951"
                        ],
                        "scopus_id": [
                            "0037195469"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/S0021-9673(02)01423-1",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/12458951",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/1619/misc/1906098",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/1619/misc",
                    "rm:id": "1906098",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2002-10-29T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-08-28T15:36:30Z",
                    "paper_title": {
                        "en": "Structural analysis of a glycoprotein by liquid chromatography-mass spectrometry and liquid chromatography with tandem mass spectrometry - Application to recombinant human thrombomodulin"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Satsuki Itoh"
                            },
                            {
                                "name": "Nana Kawasaki"
                            },
                            {
                                "name": "Miyako Ohta"
                            },
                            {
                                "name": "Takao Hayakawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "Using recombinant human thrombomodulin (rhTM) expressed in Chinese hamster ovary (CHO) cells, we studied the structural analysis of a glycoprotein by liquid chromatography-mass spectrometry (LC-MS) and liquid chromatography with tandem mass spectrometry (LC-MS-MS). First, we analyzed the structure of both the O- and N-linked glycans in rhTM by oligosaccharide mapping using LC-MS equipped with a graphitized carbon column (GCC-LC-MS). Major O- and N-linked glycans were determined to be core 1 structure and fucosyl biantennary containing NeuAc0-2, respectively. Next, the post-translational modifications and their heterogeneities, including the site-specific glycosylation, were analyzed by mass spectrometric peptide/glycopeptide mapping of trypsin-digested rhTM and precursor-ion scanning. Precursor-ion scanning was successful in the detection of five glycopeptides. Four N-glycosylation sites and their site-specific carbohydrate heterogeneity were determined by their mass spectra. O-Glycosylation could be estimated on the basis of its mass spectrum. We were able to identify partial β-hydroxylation on Asn324 and Asn439, and O-linked glucose on Ser287 from the peptide/glycopeptide map and their mass spectra. We demonstrated that a sequential analysis of LC-MS and LC-MS-MS are very useful for the structural analysis of O- and N-linked glycans, polypeptides, and post-translational modifications and their heterogeneities, including site-specific glycosylation in a glycoprotein. Our method can be applied to a glycoprotein in biological samples. © 2002 Elsevier Science B.V. All rights reserved."
                    },
                    "publication_date": "2002-11-29",
                    "publication_name": {
                        "en": "Journal of Chromatography A"
                    },
                    "volume": "978",
                    "number": "1-2",
                    "starting_page": "141",
                    "ending_page": "152",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/S0021-9673(02)01423-1"
                        ],
                        "issn": [
                            "0021-9673"
                        ],
                        "pm_id": [
                            "12458951"
                        ],
                        "scopus_id": [
                            "0037195469"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/S0021-9673(02)01423-1",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/12458951",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/1619/misc/1906105",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/1619/misc",
                    "rm:id": "1906105",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2002-10-29T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-08-28T21:25:01Z",
                    "paper_title": {
                        "en": "Activins A, AB, and B inhibit hepatocyte growth factor synthesis by MRC-5 human lung fibroblasts"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Shingo Niimi"
                            },
                            {
                                "name": "Masashi Hyuga"
                            },
                            {
                                "name": "Hiromi Kazama"
                            },
                            {
                                "name": "Masami Inagawa"
                            },
                            {
                                "name": "Taiichiro Seki"
                            },
                            {
                                "name": "Toyohiko Ariga"
                            },
                            {
                                "name": "Tetsu Kobayashi"
                            },
                            {
                                "name": "Takao Hayakawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "The effect of activins A, AB, and B on hepatocyte growth factor (HGF) synthesis stimulated by 12-O-tetradecanoylphorbol β-acetate (TPA) was studied in MRC-5 human lung fibroblasts. Activins A, AB, and B inhibited the increase in HGF secretion induced by TPA in different dose-dependent manners and potencies. At 5 ng/ml, activins A and AB inhibited the increase approximately 30% and 10%, respectively, and at 25 ng/ml both activins produced almost maximal inhibition, i.e., approximately 40%. Activin B caused 10% inhibition at 12 ng/ml, and at 25 ng/ml produced almost maximal inhibition, approximately 30%. Further analysis with activin A indicated that the inhibition was caused by decreased HGF mRNA levels, followed by decreased cellular HGF levels. At 25 ng/ml, activin A inhibited the increase in HGF in the cellular lysate and the increase in HGF mRNA level approximately 80% and 40%, respectively."
                    },
                    "publication_date": "2002-11",
                    "publication_name": {
                        "en": "Biological and Pharmaceutical Bulletin"
                    },
                    "volume": "25",
                    "number": "11",
                    "starting_page": "1405",
                    "ending_page": "1408",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1248/bpb.25.1405"
                        ],
                        "issn": [
                            "0918-6158"
                        ],
                        "pm_id": [
                            "12419948"
                        ],
                        "scopus_id": [
                            "0345153375"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1248/bpb.25.1405",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/12419948",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/1619/misc/1906099",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/1619/misc",
                    "rm:id": "1906099",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2002-10-29T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-01T01:18:08Z",
                    "paper_title": {
                        "en": "Usefulness of glycopeptide mapping by liquid chromatography/mass spectrometry in comparability assessment of glycoprotein products"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "M Ohta"
                            },
                            {
                                "name": "N Kawasaki"
                            },
                            {
                                "name": "S Itoh"
                            },
                            {
                                "name": "T Hayakawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "We previously reported on glycopeptide mapping of erythropoietin (EPO) by liquid chromatography/mass spectrometry (LC/MS). Using this method, glycopeptides in proteolytic digestion can be eluted before peptides, and are further separated on the basis of the carbohydrate structure. The detailed glycosylation at each glycosylation site can be elucidated based on mass chromatography and mass spectroscopy. In this study, we evaluated glycopeptide mapping with regard to its use in comparability assessment of glycoprotein products possessing multiple glycosylation sites. Models of closely related glycoprotein products used in this study are EPOs produced from three different sources. We previously reported that there are differences in the carbohydrate heterogeneity of these EPOs with regard to sialylation, acetylation, and sulphation patterns, using sugar mapping by LC/MS. In this paper, we demonstrated that glycopeptide mapping can distinguish site-specific glycosylation among these three EPOs and reveal the differences in acetylation, sialylation, and sulphation at each glycosylation site in one analysis. Our method can thus be useful in comparability assessment of therapeutic glycoproteins in terms of glycosylation. (C) 2002 The International Association for Biologicals. Published by Elsevier Science Ltd. All rights reserved."
                    },
                    "publisher": {
                        "en": "ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD"
                    },
                    "publication_date": "2002-09",
                    "publication_name": {
                        "en": "BIOLOGICALS"
                    },
                    "volume": "30",
                    "number": "3",
                    "starting_page": "235",
                    "ending_page": "244",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1006/biol.2002.0339"
                        ],
                        "issn": [
                            "1045-1056"
                        ],
                        "wos_id": [
                            "WOS:000178276600007"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1006/biol.2002.0339",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000178276600007&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/1619/misc/1906092",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/1619/misc",
                    "rm:id": "1906092",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2002-10-29T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-08-28T15:37:59Z",
                    "paper_title": {
                        "en": "Simultaneous microanalysis of N-linked oligosaccharides in a glycoprotein using microbore graphitized carbon column liquid chromatography-mass spectrometry"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Satsuki Itoh"
                            },
                            {
                                "name": "Nana Kawasaki"
                            },
                            {
                                "name": "Miyako Ohta"
                            },
                            {
                                "name": "Masashi Hyuga"
                            },
                            {
                                "name": "Sumiko Hyuga"
                            },
                            {
                                "name": "Takao Hayakawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "We previously reported that graphitized carbon column liquid chromatography-mass spectrometry (GCC-LC-MS) is very useful for the structural analysis of carbohydrates in a glycoprotein. In this study, GCC-LC-MS was adapted for the simultaneous microanalysis of oligosaccharides. A variety of oligosaccharide alditols prepared from fetuin, ribonuclease B, and recombinant human erythropoietin were used as model oligosaccharides. The use of microbore GCC-LC-MS was found to be successful for rapid, sensitive, and simultaneous analysis of high-mannose-type, desialylated fucosyl complex-type, sialylated complex-type, and sialylated fucosyl complex-type oligosaccharide alditols. Furthermore, we demonstrate that this method is applicable to the analysis of carbohydrate heterogeneity in a glycoprotein that possesses diverse oligosaccharides. Microbore GCC-LC-MS was able to characterize high-mannose-type, hybrid-type, and complex-type oligosaccharides in tissue plasminogen activator produced from human melanoma cells in a single analysis. © 2002 Elsevier Science B.V. All rights reserved."
                    },
                    "publication_date": "2002-08-30",
                    "publication_name": {
                        "en": "Journal of Chromatography A"
                    },
                    "volume": "968",
                    "number": "1-2",
                    "starting_page": "89",
                    "ending_page": "100",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/S0021-9673(02)00951-2"
                        ],
                        "issn": [
                            "0021-9673"
                        ],
                        "pm_id": [
                            "12236519"
                        ],
                        "scopus_id": [
                            "0037199635"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/S0021-9673(02)00951-2",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/12236519",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/1619/misc/1906093",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/1619/misc",
                    "rm:id": "1906093",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2002-10-29T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-08-28T15:18:00Z",
                    "paper_title": {
                        "en": "Strength evaluation of transcriptional regulatory elements for transgene expression by adenovirus vector"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Zhi-Li Xu"
                            },
                            {
                                "name": "Hiroyuki Mizuguchi"
                            },
                            {
                                "name": "Akiko Ishii-Watabe"
                            },
                            {
                                "name": "Eriko Uchida"
                            },
                            {
                                "name": "Tadanori Mayumi"
                            },
                            {
                                "name": "Takao Hayakawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "In studies of both gene function and gene therapy, transgene expression may be assisted considerably through the use of transcriptional regulatory elements with high activity. In this study, we evaluated the strength of various transcriptional regulatory elements both in vitro (six types of cell line) and in vivo (mouse heart, lung, kidney, spleen, and liver) by adenovirus-mediated gene transfer. In the case of the promoter/enhancer (P/E), the activity of CMV P/E (from the human cytomegalovirus immediate-early 1 gene) and hybrid CA P/E (composed of the CMV enhancer and chicken β-actin promoter) were investigated, both of which are known to be strong and widely used. While hybrid CA P/E showed a higher transgene expression activity than CMV P/E, the addition of the intron A sequence (the largest intron of CMV) to CMV P/E increased the activity of CMV P/E to the same or higher level than that of hybrid CA P/E. Concerning the polyadenylation signal (P(A)) sequence, one from the bovine growth hormone (BGH) gene was about two times more efficient than that from the Simian virus 40 (SV40) late gene, both in vitro and in vivo. In the context of the CMV P/E containing the intron A sequence, a further increase in transgene expression was obtained by the addition of a SV40 enhancer downstream from the P(A) sequence. The combination of the SV40 P(A) and a SV40 enhancer showed almost comparable activity to BGH P(A). This information would be helpful for the construction of adenovirus vectors for studies regarding both gene function and gene therapy. © Elsevier Science B.V. All rights reserved."
                    },
                    "publication_date": "2002-05-17",
                    "publication_name": {
                        "en": "Journal of Controlled Release"
                    },
                    "volume": "81",
                    "number": "1-2",
                    "starting_page": "155",
                    "ending_page": "163",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/S0168-3659(02)00059-7"
                        ],
                        "issn": [
                            "0168-3659"
                        ],
                        "pm_id": [
                            "11992688"
                        ],
                        "scopus_id": [
                            "0037123721"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/S0168-3659(02)00059-7",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/11992688",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/1619/misc/1906144",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/1619/misc",
                    "rm:id": "1906144",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2002-10-29T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-01T06:33:12Z",
                    "paper_title": {
                        "en": "The tet-off system is more effective than the tet-on system for regulating transgene expression in a single adenovirus vector"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "H Mizuguchi"
                            },
                            {
                                "name": "T Hayakawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "Background Control of transgene expression in mammalian cells is desirable for gene therapy and the study of gene function in basic research. This study evaluates the functionality of single adenovirus (Ad) vectors containing a tetracycline-controllable expression system (tet-off or tet-on system).\nMethods An Ad-mediated binary transgene expression system was generated containing a tet-off or a tet-on system, which introduced the gene of interest with a tetracycline-regulatable promoter and the tetracycline-responsive transcriptional activator gene into the E1 and E3 deletion regions, respectively. The functionality of the Ad-mediated tet-off and tet-on systems was compared under various conditions in vitro and in vivo.\nResults The Ad vector containing the tet-off system provided negative control of gene expression ranging from 20- to 500-fold, depending on the cell type and condition. In contrast, the Ad vector containing the tet-on system increased gene expression by only 2- to 28-fold and required about two-log orders higher concentration of an inducer (doxycycline) to switch on the gene expression, compared with the Ad vector containing the tet-off system.\nConclusion Ad vectors containing the tet-off system are a better choice for regulated gene expression than Ad vectors containing the tet-on system. Single Ad vectors containing the tetracycline-controllable expression system will greatly facilitate in vitro and in vivo analyses of gene function and may be useful for gene therapy. Copyright (C) 2002 John Wiley Sons, Ltd."
                    },
                    "publisher": {
                        "en": "JOHN WILEY & SONS LTD"
                    },
                    "publication_date": "2002-05",
                    "publication_name": {
                        "en": "JOURNAL OF GENE MEDICINE"
                    },
                    "volume": "4",
                    "number": "3",
                    "starting_page": "240",
                    "ending_page": "247",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1002/jgm.261"
                        ],
                        "issn": [
                            "1099-498X"
                        ],
                        "wos_id": [
                            "WOS:000176617400002"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1002/jgm.261",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000176617400002&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/1619/misc/1906145",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/1619/misc",
                    "rm:id": "1906145",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2002-10-29T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-04-30T23:19:39Z",
                    "paper_title": {
                        "en": "Autoinhibitory regulation of p73 by Delta Np73 to modulate cell survival and death through a p73-specific target element within the Delta Np73 promoter"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "T Nakagawa"
                            },
                            {
                                "name": "M Takahashi"
                            },
                            {
                                "name": "T Ozaki"
                            },
                            {
                                "name": "K Watanabe"
                            },
                            {
                                "name": "S Todo"
                            },
                            {
                                "name": "H Mizuguchi"
                            },
                            {
                                "name": "T Hayakawa"
                            },
                            {
                                "name": "A Nakagawara"
                            }
                        ]
                    },
                    "description": {
                        "en": "p73 is a p53-related tumor suppressor but is also induced by oncogene products such as E2F-1, raising a question as to whether p73 is a tumor suppressor gene or oncogene. Unlike p53, p73 has several variants, including DeltaNp73, which lacks the NH2-terminal transactivation domain. Although, in developing neurons, DeltaNp73 is expressed abundantly and seems to inhibit the proapoptotic function of p53, the role of p73 and DeltaNp73 and their regulatory mechanism in cell growth and differentiation are poorly understood. Here we report that p73, but not p53, directly activates the transcription of endogenous Delta-Np73 by binding to the p73-specific target element located at positions -76 to -57 within the DeltaNp73 promoter region. The activation of DeltaNp73 promoter by p63 was marginal. DeltaNp73 was associated with p73alpha, p73beta, and p53, as demonstrated by immunoprecipitation assays, and inhibited their transactivation activities when we used reporters of Mdm2, Bax, or DeltaNp73 itself in SAOS-2 cells. Furthermore, induction or overexpression of DeltaNp73 promoted cell survival by competing with p53 and p73 itself. Thus, our results suggest that the negative feedback regulation of p73 by its target DeltaNp73 is a novel autoregulatory system for modulating cell survival and death."
                    },
                    "publisher": {
                        "en": "AMER SOC MICROBIOLOGY"
                    },
                    "publication_date": "2002-04",
                    "publication_name": {
                        "en": "MOLECULAR AND CELLULAR BIOLOGY"
                    },
                    "volume": "22",
                    "number": "8",
                    "starting_page": "2575",
                    "ending_page": "2585",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1128/MCB.22.8.2575-2585.2002"
                        ],
                        "issn": [
                            "0270-7306"
                        ],
                        "wos_id": [
                            "WOS:000174635700015"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1128/MCB.22.8.2575-2585.2002",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000174635700015&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/1619/misc/1906097",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/1619/misc",
                    "rm:id": "1906097",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2002-10-29T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-08-28T15:07:04Z",
                    "paper_title": {
                        "en": "A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Yuji Nagayama"
                            },
                            {
                                "name": "Masako Kita-Furuyama"
                            },
                            {
                                "name": "Takao Ando"
                            },
                            {
                                "name": "Kazuhiko Nakao"
                            },
                            {
                                "name": "Hiroyuki Mizuguchi"
                            },
                            {
                                "name": "Takao Hayakawa"
                            },
                            {
                                "name": "Katsumi Eguchi"
                            },
                            {
                                "name": "Masami Niwa"
                            }
                        ]
                    },
                    "description": {
                        "en": "In this work we report a novel method to efficiently induce a murine model of Graves' hyperthyroidism. Inbred mice of different strains were immunized by i.m. injection with adenovirus expressing thyrotropin receptor (TSHR) or β-galactosidase (1 × 1011 particles/mouse, three times at 3-wk intervals) and followed up to 8 wk after the third immunization. Fifty-five percent of female and 33% of male BALB/c (H-2d) and 25% of female C57BL/6 (H-2b) mice developed Graves'-like hyperthyroidism with elevated serum thyroxine (T4) levels and positive anti-TSHR autoantibodies with thyroid-stimulating Ig (TSI) and TSH-binding inhibiting Ig (TBII) activities. In contrast, none of female CBM/J (H-2k), DBM/1J (H-2q), or SJL/J (H-2s) mice developed Graves' hyperthyroidism or anti-TSHR autoantibodies except SJL/J, which showed strong TBII activities. There was a significant positive correlation between TSI values and T4 levels, but the correlations between T4 and TBII and between TSI and TBII were very weak. TSI activities in sera from hyperthyroid mice measured with some chimeric TSH/lutropin receptors suggested that their epitope(s) on TSHR appeared similar to those in patients with Graves' disease. The thyroid glands from hyperthyroid mice displayed diffuse enlargement with hypertrophy and hypercellularity of follicular epithelia with occasional protrusion into the follicular lumen, characteristics of Graves' hyperthyroidism. Decreased amounts of colloid were also observed. However, there was no inflammatory cell infiltration. Furthermore, extraocular muscles from hyperthyroid mice were normal. Thus, the highly efficient means that we now report to induce Graves' hyperthyroidism in mice will be very useful for studying the pathogenesis of autoimmunity in Graves' disease."
                    },
                    "publisher": {
                        "en": "American Association of Immunologists"
                    },
                    "publication_date": "2002-03-15",
                    "publication_name": {
                        "en": "Journal of Immunology"
                    },
                    "volume": "168",
                    "number": "6",
                    "starting_page": "2789",
                    "ending_page": "2794",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.4049/jimmunol.168.6.2789"
                        ],
                        "issn": [
                            "0022-1767"
                        ],
                        "pm_id": [
                            "11884447"
                        ],
                        "scopus_id": [
                            "0037087373"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.4049/jimmunol.168.6.2789",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/11884447",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/1619/misc/1906148",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/1619/misc",
                    "rm:id": "1906148",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2002-10-29T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-08-28T14:55:54Z",
                    "paper_title": {
                        "en": "Fiber-mutant technique can augment gene transduction efficacy and anti-tumor effects against established murine melanoma by cytokine-gene therapy using adenovirus vectors"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Yuka Okada"
                            },
                            {
                                "name": "Naoki Okada"
                            },
                            {
                                "name": "Shinsaku Nakagawa"
                            },
                            {
                                "name": "Hiroyuki Mizuguchi"
                            },
                            {
                                "name": "Makiko Kanehira"
                            },
                            {
                                "name": "Naoko Nishino"
                            },
                            {
                                "name": "Koichi Takahashi"
                            },
                            {
                                "name": "Nobuyasu Mizuno"
                            },
                            {
                                "name": "Takao Hayakawa"
                            },
                            {
                                "name": "Tadanori Mayumi"
                            }
                        ]
                    },
                    "description": {
                        "en": "Melanoma cells are relatively resistant to adenovirus vector (Ad)-mediated gene transfer due to the low expression of Coxsackie-adenovirus receptor (CAR), which acts as a primitive Ad-receptor. Therefore, extremely high doses of Ad are required for effective gene therapy against melanoma. In the present study, we investigated whether fiber-mutant Ad containing the Arg-Gly-Asp (RGD) sequence in the fiber knob could promote gene delivery and anti-tumor effects in the murine B16 BL6 tumor model. B16 BL6 cells (in vitro) and tumors (in vivo) infected with RGD fiber-mutant Ad containing a tumor necrosis factor α gene (Ad-RGD-TNFα) produced more TNFα than those infected with conventional Ad-TNFα. In addition, Ad-RGD-TNFα required about one-tenth the dosage of Ad-TNFα for induction of equal therapeutic effects upon intratumoral injection into established B16 BL6 tumors. Furthermore, the combination of both TNFα- and interleukin 12-expressing RGD fiber-mutant Ads exhibited more effective tumor regression than the Ad expressing each alone. These results suggested that the fiber-mutant for altering Ad-tropism is a very potent technology for advancing gene therapy for melanoma. © 2002 Elsevier Science Ireland Ltd. All rights reserved."
                    },
                    "publication_date": "2002-03-08",
                    "publication_name": {
                        "en": "Cancer Letters"
                    },
                    "volume": "177",
                    "number": "1",
                    "starting_page": "57",
                    "ending_page": "63",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/S0304-3835(01)00768-6"
                        ],
                        "issn": [
                            "0304-3835"
                        ],
                        "pm_id": [
                            "11809531"
                        ],
                        "scopus_id": [
                            "0037040436"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/S0304-3835(01)00768-6",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/11809531",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/1619/misc/1906074",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/1619/misc",
                    "rm:id": "1906074",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2002-10-29T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-08-28T14:55:54Z",
                    "paper_title": {
                        "en": "Fiber-mutant technique can augment gene transduction efficacy and anti-tumor effects against established murine melanoma by cytokine-gene therapy using adenovirus vectors"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "Yuka Okada"
                            },
                            {
                                "name": "Naoki Okada"
                            },
                            {
                                "name": "Shinsaku Nakagawa"
                            },
                            {
                                "name": "Hiroyuki Mizuguchi"
                            },
                            {
                                "name": "Makiko Kanehira"
                            },
                            {
                                "name": "Naoko Nishino"
                            },
                            {
                                "name": "Koichi Takahashi"
                            },
                            {
                                "name": "Nobuyasu Mizuno"
                            },
                            {
                                "name": "Takao Hayakawa"
                            },
                            {
                                "name": "Tadanori Mayumi"
                            }
                        ]
                    },
                    "description": {
                        "en": "Melanoma cells are relatively resistant to adenovirus vector (Ad)-mediated gene transfer due to the low expression of Coxsackie-adenovirus receptor (CAR), which acts as a primitive Ad-receptor. Therefore, extremely high doses of Ad are required for effective gene therapy against melanoma. In the present study, we investigated whether fiber-mutant Ad containing the Arg-Gly-Asp (RGD) sequence in the fiber knob could promote gene delivery and anti-tumor effects in the murine B16 BL6 tumor model. B16 BL6 cells (in vitro) and tumors (in vivo) infected with RGD fiber-mutant Ad containing a tumor necrosis factor α gene (Ad-RGD-TNFα) produced more TNFα than those infected with conventional Ad-TNFα. In addition, Ad-RGD-TNFα required about one-tenth the dosage of Ad-TNFα for induction of equal therapeutic effects upon intratumoral injection into established B16 BL6 tumors. Furthermore, the combination of both TNFα- and interleukin 12-expressing RGD fiber-mutant Ads exhibited more effective tumor regression than the Ad expressing each alone. These results suggested that the fiber-mutant for altering Ad-tropism is a very potent technology for advancing gene therapy for melanoma. © 2002 Elsevier Science Ireland Ltd. All rights reserved."
                    },
                    "publication_date": "2002-03-08",
                    "publication_name": {
                        "en": "Cancer Letters"
                    },
                    "volume": "177",
                    "number": "1",
                    "starting_page": "57",
                    "ending_page": "63",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1016/S0304-3835(01)00768-6"
                        ],
                        "issn": [
                            "0304-3835"
                        ],
                        "pm_id": [
                            "11809531"
                        ],
                        "scopus_id": [
                            "0037040436"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1016/S0304-3835(01)00768-6",
                            "is_downloadable": false
                        },
                        {
                            "label": "pubmed",
                            "@id": "https://www.ncbi.nlm.nih.gov/pubmed/11809531",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/1619/misc/1906146",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/1619/misc",
                    "rm:id": "1906146",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2002-10-29T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-01T18:32:06Z",
                    "paper_title": {
                        "en": "Establishment of a standard assay method for human thrombomodulin and determination of the activity of the Japanese reference standard"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "S Niimi"
                            },
                            {
                                "name": "T Oshizawa"
                            },
                            {
                                "name": "M Naotsuka"
                            },
                            {
                                "name": "S Ohba"
                            },
                            {
                                "name": "A Yokozawa"
                            },
                            {
                                "name": "T Murata"
                            },
                            {
                                "name": "T Hayakawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "This study was undertaken to establish a standard method for determination of the activity of human (h) thrombomodulin (TM). The reactions mainly consisted of formation of a h-TM and h-thrombin complex, activation of h-protein C by the complex and digestion of substrate by activated h-protein C, Linear time-dependent formation of p-nitroaniline from the substrate, S-2366, was observed up to 12 min during measurement of the activity of urinary h-TM (uh-TM) reference material by the standard method. Therefore, 10 minutes was established as the reaction time in the standard method, In the standard method, we defined the activity of h-TM forming 0(.)1 mumol of p-nitroaniline per min in the reaction as 1 JRS Unit. Recombinant h-TM (rh-TM) and uh-TM reference material gave rectilinear dose-response curves within a certain range of specific activities by their original methods in the standard method. The validity of the standard method was assessed based on the coefficients of variation (CV) obtained in the various measurements of h-TM, Intra-batch precision (CV) of h-thrombin and h-protein C was 2(.)90% and 6(.)57%, respectively, in the measurement of uh-TM activity. The intra-sample, inter-day, and inter-laboratory precision (CV) was 1(.)30%, 1(.)63% and 5(.)02%, respectively, in the measurement of the first Japanese reference standard for h-TM coded TJRS1. In these assays, the activity of the first Japanese standard was also determined and found to be 205 JRS units per ampoule. When the stability of the Japanese reference standard was assessed by measuring of the standard stored under various thermal conditions, the predicted loss of activity assuming monomolecular degradation according to the Arrhenius equation was less than 3(.)0% during 103 years at -20degreesC. These results indicate that the standard method is appropriate for determination of the activity of h-TM and that the Japanese reference standard for h-TM, whose activity was determined here, can be stored at -20degreesC for long periods without loss of activity. (C) 2002 The International Association for Biologicals."
                    },
                    "publisher": {
                        "en": "ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD"
                    },
                    "publication_date": "2002-03",
                    "publication_name": {
                        "en": "BIOLOGICALS"
                    },
                    "volume": "30",
                    "number": "1",
                    "starting_page": "69",
                    "ending_page": "76",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1006/biol.2001.0318"
                        ],
                        "issn": [
                            "1045-1056"
                        ],
                        "wos_id": [
                            "WOS:000173472900008"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1006/biol.2001.0318",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000173472900008&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/1619/misc/1906143",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/1619/misc",
                    "rm:id": "1906143",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2002-10-29T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-01T18:12:43Z",
                    "paper_title": {
                        "en": "Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "H Mizuguchi"
                            },
                            {
                                "name": "T Hayakawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "There are at least two hurdles confronting the use of the adenovirus (Ad) -mediated herpes simplex virus thymidine kinase (HSVtk)/ ganciclovir (GCV) system for the treatment of cancer. One is inefficient Ad vector-mediated gene transfer into tumor cells lacking the primary receptor, i.e., the coxsackievirus and adenovirus receptor (CAR). The other is hepatotoxicity due to unwanted vector spread into the liver, even when Ad vectors are injected intratumorally. Herein, we present an attractive strategy for overcoming such limitations based on use of a fiber-modified Ad vector containing an RGD peptide motif in the fiber knob. HSVtk-expressing Ad vectors containing mutant fiber (AdRGD-tk) or wild-type fiber (Ad-tk) were injected intratumorally into CAR-negative B16 melanoma cells inoculated into mice, after which GCV was injected intraperitoneally for 10 days. AdRGD-tk showed approximately 25 times more antitumor activity than Ad-tk. Histopathological studies suggested that liver damage in mice injected with AdRGD-tk was significantly lower than that in mice injected with Ad-tk. Intratumoral administration of luciferase-expressing Ad vectors containing the mutant fiber (AdRGD-L2) resulted in nearly 40 times more luciferase production in the tumor, but 8 times less production in the liver than the conventional Ad vectors (Ad-L2). These results indicate that combination of fiber-modified vectors and a HSVtk/GCV system is a potentially useful and safe approach for the treatment of tumors lacking CAR expression, and that fiber-modified vectors could be of great utility for gene therapy and gene transfer experiments."
                    },
                    "publisher": {
                        "en": "NATURE PUBLISHING GROUP"
                    },
                    "publication_date": "2002-03",
                    "publication_name": {
                        "en": "CANCER GENE THERAPY"
                    },
                    "volume": "9",
                    "number": "3",
                    "starting_page": "236",
                    "ending_page": "242",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1038/sj/cgt/7700440"
                        ],
                        "issn": [
                            "0929-1903"
                        ],
                        "wos_id": [
                            "WOS:000174217200003"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1038/sj/cgt/7700440",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000174217200003&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/1619/misc/1906072",
                    "@type": "misc",
                    "@reverse": "https://api.researchmap.jp/1619/misc",
                    "rm:id": "1906072",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2002-10-29T15:00:00Z",
                    "rm:modifier_id": "ai:identify_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2020-05-01T18:32:06Z",
                    "paper_title": {
                        "en": "Establishment of a standard assay method for human thrombomodulin and determination of the activity of the Japanese reference standard"
                    },
                    "authors": {
                        "en": [
                            {
                                "name": "S Niimi"
                            },
                            {
                                "name": "T Oshizawa"
                            },
                            {
                                "name": "M Naotsuka"
                            },
                            {
                                "name": "S Ohba"
                            },
                            {
                                "name": "A Yokozawa"
                            },
                            {
                                "name": "T Murata"
                            },
                            {
                                "name": "T Hayakawa"
                            }
                        ]
                    },
                    "description": {
                        "en": "This study was undertaken to establish a standard method for determination of the activity of human (h) thrombomodulin (TM). The reactions mainly consisted of formation of a h-TM and h-thrombin complex, activation of h-protein C by the complex and digestion of substrate by activated h-protein C, Linear time-dependent formation of p-nitroaniline from the substrate, S-2366, was observed up to 12 min during measurement of the activity of urinary h-TM (uh-TM) reference material by the standard method. Therefore, 10 minutes was established as the reaction time in the standard method, In the standard method, we defined the activity of h-TM forming 0(.)1 mumol of p-nitroaniline per min in the reaction as 1 JRS Unit. Recombinant h-TM (rh-TM) and uh-TM reference material gave rectilinear dose-response curves within a certain range of specific activities by their original methods in the standard method. The validity of the standard method was assessed based on the coefficients of variation (CV) obtained in the various measurements of h-TM, Intra-batch precision (CV) of h-thrombin and h-protein C was 2(.)90% and 6(.)57%, respectively, in the measurement of uh-TM activity. The intra-sample, inter-day, and inter-laboratory precision (CV) was 1(.)30%, 1(.)63% and 5(.)02%, respectively, in the measurement of the first Japanese reference standard for h-TM coded TJRS1. In these assays, the activity of the first Japanese standard was also determined and found to be 205 JRS units per ampoule. When the stability of the Japanese reference standard was assessed by measuring of the standard stored under various thermal conditions, the predicted loss of activity assuming monomolecular degradation according to the Arrhenius equation was less than 3(.)0% during 103 years at -20degreesC. These results indicate that the standard method is appropriate for determination of the activity of h-TM and that the Japanese reference standard for h-TM, whose activity was determined here, can be stored at -20degreesC for long periods without loss of activity. (C) 2002 The International Association for Biologicals."
                    },
                    "publisher": {
                        "en": "ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD"
                    },
                    "publication_date": "2002-03",
                    "publication_name": {
                        "en": "BIOLOGICALS"
                    },
                    "volume": "30",
                    "number": "1",
                    "starting_page": "69",
                    "ending_page": "76",
                    "languages": [
                        "eng"
                    ],
                    "referee": false,
                    "invited": false,
                    "rm:is_open_access": false,
                    "identifiers": {
                        "doi": [
                            "10.1006/biol.2001.0318"
                        ],
                        "issn": [
                            "1045-1056"
                        ],
                        "wos_id": [
                            "WOS:000173472900008"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "doi",
                            "@id": "https://doi.org/10.1006/biol.2001.0318",
                            "is_downloadable": false
                        },
                        {
                            "label": "web_of_science",
                            "@id": "https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000173472900008&DestApp=WOS_CPL",
                            "is_downloadable": false
                        }
                    ]
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/1619/association_memberships",
            "@type": "association_memberships",
            "@reverse": "https://api.researchmap.jp/1619",
            "total_items": 5,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/1619/association_memberships/328522",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/1619/association_memberships",
                    "rm:id": "328522",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2002-10-29T15:00:00Z",
                    "rm:modifier_id": "0000041130",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2002-10-29T15:00:00Z",
                    "academic_society_name": {
                        "en": "The Pharmaceutical Society of Japan"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/1619/association_memberships/328521",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/1619/association_memberships",
                    "rm:id": "328521",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2002-10-29T15:00:00Z",
                    "rm:modifier_id": "0000041130",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2002-10-29T15:00:00Z",
                    "academic_society_name": {
                        "en": "The Japanese Society of Immunology"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/1619/association_memberships/328520",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/1619/association_memberships",
                    "rm:id": "328520",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2002-10-29T15:00:00Z",
                    "rm:modifier_id": "0000041130",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2002-10-29T15:00:00Z",
                    "academic_society_name": {
                        "en": "The Japanese Cancer Association"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/1619/association_memberships/328519",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/1619/association_memberships",
                    "rm:id": "328519",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2002-10-29T15:00:00Z",
                    "rm:modifier_id": "0000041130",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2002-10-29T15:00:00Z",
                    "academic_society_name": {
                        "en": "The Japanese Biochemical Society"
                    }
                },
                {
                    "@id": "https://api.researchmap.jp/1619/association_memberships/328518",
                    "@type": "association_memberships",
                    "@reverse": "https://api.researchmap.jp/1619/association_memberships",
                    "rm:id": "328518",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "0000041130",
                    "rm:creator_type": "myself",
                    "rm:created": "2002-10-29T15:00:00Z",
                    "rm:modifier_id": "0000041130",
                    "rm:modifier_type": "myself",
                    "rm:modified": "2002-10-29T15:00:00Z",
                    "academic_society_name": {
                        "en": "International Association for Biologicals"
                    }
                }
            ]
        },
        {
            "@id": "https://api.researchmap.jp/1619/research_projects",
            "@type": "research_projects",
            "@reverse": "https://api.researchmap.jp/1619",
            "total_items": 5,
            "items": [
                {
                    "@id": "https://api.researchmap.jp/1619/research_projects/45230299",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/1619/research_projects",
                    "rm:id": "45230299",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_internal_feeds",
                    "rm:creator_type": "ai",
                    "rm:created": "2024-01-30T19:16:26Z",
                    "rm:modifier_id": "ai:assign_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2024-01-30T19:16:26Z",
                    "research_project_title": {
                        "ja": "新規脂肪組織由来幹細胞を用いた重症心不全に対する画期的治療法の開発",
                        "en": "ADMPCs as a promising tool for cardiac regeneration"
                    },
                    "investigators": {
                        "ja": [
                            {
                                "name": "松山 晃文"
                            },
                            {
                                "name": "早川 堯夫"
                            },
                            {
                                "name": "李 千萬"
                            },
                            {
                                "name": "菰田 弘"
                            }
                        ],
                        "en": [
                            {
                                "name": "MATSUYAMA Akifumi"
                            },
                            {
                                "name": "HAYAKAWA Takao"
                            },
                            {
                                "name": "LEE Chun-man"
                            },
                            {
                                "name": "KOMODA Hiroshi"
                            }
                        ]
                    },
                    "offer_organization": {
                        "ja": "日本学術振興会",
                        "en": "Japan Society for the Promotion of Science"
                    },
                    "system_name": {
                        "ja": "科学研究費助成事業",
                        "en": "Grants-in-Aid for Scientific Research"
                    },
                    "category": {
                        "ja": "基盤研究(B)",
                        "en": "Grant-in-Aid for Scientific Research (B)"
                    },
                    "institution_name": {
                        "en": "Foundation for Biomedical Research and Innovation"
                    },
                    "from_date": "2009",
                    "to_date": "2011",
                    "overall_grant_amount": {
                        "total_cost": "17940000",
                        "direct_cost": "13800000",
                        "indirect_cost": "4140000"
                    },
                    "description": {
                        "ja": "従来の治療法で治療しえない重症心不全に対する心筋再生治療法の研究開発は急務である。研究開始までに我々が開発してきた新規の脂肪組織幹細胞を高機能化させる技術を基盤とし、脂肪組織幹細胞由来再生心筋芽細胞の高機能化をはかった。nkx2.5をマーカーとして脂肪組織由来幹細胞を心筋芽細胞へと高機能化する培養条件検討と薬剤のスクリーニングを実施し、低分子化合物ライブラリー(のべ約2000種類)から、添加培養により心筋マーカーであるalpha-Cardiac actin、Myosin Light Chain、Cardiac troponin I、Myosin Heavy Chainのすべての発現を誘導する薬剤として\"polyamine\"のスクリーニングに成功し、特許出願を行った。ついで、これら高機能化心筋芽細胞の有用性を確認するための大動物モデルの構築を試みた。重症心不全モデルブタとして2段階梗塞作製法による重症心不全モデルを用い、高機能化誘導心筋芽細胞の有効性を検証した。大阪大学心臓血管外科及び(独)理化学研究所と共同で心駆出率が30%～35%の重篤な慢性心筋梗塞モデルブタを作製、高機能化心筋芽細胞を投与したところ、心駆出率は45%～55%に改善することを見出した。",
                        "en": "Background : Polyamines has been reported to make embryonic stem cells differentiate into cardiac lineage. In this study, we examined whether spermine could commit human adipose tissue. derived multi-lineage progenitor cells(hADMPCs) into cardiac lineage and whether the polyamine treated-hADMPCs would differentiate into cardiomyocytes-like cells and improve left ventricular dysfunction in a swine chronic myocardial infarction model. Methods and Results : After 24h-treatment with polyamine, hADMPCs showed the augmentation of cardiac marker-expressions ; nkx2.5, islet-1, alpha-cardiac actin and cardiac troponin I(11.2-, 27.5-, 43.6-and 19.1-fold to hADMPCs per se, respectively). To examine the effect of polyamine treated-hADMPCs on left ventricular dysfunction, swine chronic MI model were built up by first ballooning and reperfusion to first diagonal branch and second one to left ascending coronary artery(# 6) 1 week-later. Four week-later second one, the swine(immunization with CyA 0.6mg i. m./kg/day) received transplantation of polyamine treated-hADMPCs(1x10^5, 3x10^5, 1x106 and 3x10^6 cells/kg) or lactic Ringer's solution via intracoronary(# 6), and echocardiogram was examined at 0, 4, 8 and 12 weeks after transplantation. Follow-up showed rescue of function in the transplanted, and the most effective dose was 3x10^5 cells/kg(EF ; 33.4%, 47.0%, 51.5% and 52.9% at 0, 4, 8 and 12 week-after transplantation, respectively). Histologically, the polyamine treated-hADMPCs were engrafted into the scarred myocardium and reprogrammed into human specific troponin I and alpha-cardiac actin positive cells in situ 12 week-after transplantation. Conclusion : The transplantation of polyamine treated-hADMPCs is a potentially effective therapeutic strategy for future cardiac tissue regeneration."
                    },
                    "identifiers": {
                        "grant_number": [
                            "21390399"
                        ],
                        "national_grant_number": [
                            "JP21390399"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "kaken",
                            "@id": "https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21390399"
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/1619/research_projects/45198910",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/1619/research_projects",
                    "rm:id": "45198910",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_internal_feeds",
                    "rm:creator_type": "ai",
                    "rm:created": "2024-01-30T18:28:40Z",
                    "rm:modifier_id": "ai:assign_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2024-01-30T18:28:40Z",
                    "research_project_title": {
                        "ja": "マイクロRNAによる遺伝子発現制御システムを搭載したアデノウイルスベクターの開発",
                        "en": "Development of an adenovirus vector containing microRNA-regulated gene expression system"
                    },
                    "investigators": {
                        "ja": [
                            {
                                "name": "櫻井 文教"
                            },
                            {
                                "name": "水口 裕之"
                            },
                            {
                                "name": "川端 健二"
                            },
                            {
                                "name": "形山 和史"
                            },
                            {
                                "name": "田代 克久"
                            },
                            {
                                "name": "近藤 昌夫"
                            },
                            {
                                "name": "八木 清仁"
                            },
                            {
                                "name": "中村 紳一朗"
                            },
                            {
                                "name": "川瀬 篤史"
                            },
                            {
                                "name": "岩城 正宏"
                            },
                            {
                                "name": "早川 尭夫"
                            },
                            {
                                "name": "藤原 俊義"
                            },
                            {
                                "name": "鈴木 孝幸"
                            },
                            {
                                "name": "杉尾 久美子"
                            },
                            {
                                "name": "清水 かほり"
                            },
                            {
                                "name": "富田 恭子"
                            }
                        ],
                        "en": [
                            {
                                "name": "SAKURAI Fuminori"
                            },
                            {
                                "name": "MIZUGUCHI Hiroyuki"
                            },
                            {
                                "name": "KAWABATA Kenji"
                            },
                            {
                                "name": "KATAYAMA Kazufumi"
                            },
                            {
                                "name": "TASHIRO Katsuhisa"
                            },
                            {
                                "name": "KONDOH Masuo"
                            },
                            {
                                "name": "YAGI Kiyohito"
                            },
                            {
                                "name": "NAKAMURA Shin-ichiro"
                            },
                            {
                                "name": "KAWASE Atsushi"
                            },
                            {
                                "name": "IWAKI Masahiro"
                            },
                            {
                                "name": "HAYAKAWA Takao"
                            },
                            {
                                "name": "FUJIWARA Toshiyoshi"
                            },
                            {
                                "name": "SUZUKI Takayuki"
                            },
                            {
                                "name": "SUGIO Kumiko"
                            },
                            {
                                "name": "SHIMIZU Kahori"
                            },
                            {
                                "name": "BENNETT David Mark Gilfedder"
                            },
                            {
                                "name": "TOMITA Kyoko"
                            }
                        ]
                    },
                    "offer_organization": {
                        "ja": "日本学術振興会",
                        "en": "Japan Society for the Promotion of Science"
                    },
                    "system_name": {
                        "ja": "科学研究費助成事業",
                        "en": "Grants-in-Aid for Scientific Research"
                    },
                    "category": {
                        "ja": "若手研究(A)",
                        "en": "Grant-in-Aid for Young Scientists (A)"
                    },
                    "institution_name": {
                        "ja": "大阪大学",
                        "en": "National Institute of Biomedical Innovation"
                    },
                    "from_date": "2008",
                    "to_date": "2010",
                    "overall_grant_amount": {
                        "total_cost": "25350000",
                        "direct_cost": "19500000",
                        "indirect_cost": "5850000"
                    },
                    "description": {
                        "ja": "本研究では、アデノウイルス(Ad)ベクターに、マイクロRNA(miRNA)による遺伝子発現制御システムを搭載することにより、miRNAの発現依存的に遺伝子の発現を制御可能な安全性の高いAdベクターを開発することに成功した。具体的には、(1)肝臓もしくは脾臓における導入遺伝子の発現を抑制可能なAdベクター、(2)Ad遺伝子の非特異的な発現を抑制可能なAdベクター、(3)正常細胞での増殖を大きく抑制した制限増殖型Adを開発した。",
                        "en": "In this study, we developed the adenovirus (Ad) vectors which exhibited enhanced safety profiles by incorporating microRNA (miRNA)-regulated gene expression system. For example, (1)an Ad vector which shows reduction in the transgene expression in the liver and spleen by insertion of sequences complementary to liver- and spleen-specific miRNA, respectively, (2) an Ad vector which exhibits reduction in the leaky expression of Ad genes by insertion of miRNA complementary sequences into 3'-untranslated region of E2A or E4 genes, (3) a oncolytic Ad which shows reduced replication in normal cells by insertion of sequences complementary to normal cell-specific miRNAs, were developed."
                    },
                    "identifiers": {
                        "grant_number": [
                            "20689004"
                        ],
                        "national_grant_number": [
                            "JP20689004"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "kaken",
                            "@id": "https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-20689004"
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/1619/research_projects/44872739",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/1619/research_projects",
                    "rm:id": "44872739",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_internal_feeds",
                    "rm:creator_type": "ai",
                    "rm:created": "2024-01-30T10:45:01Z",
                    "rm:modifier_id": "ai:assign_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2024-01-30T10:45:01Z",
                    "research_project_title": {
                        "ja": "新規遺伝子治療薬創製のための発現調節機能を備えた安定な外来遺伝子発現系の開発",
                        "en": "Development of stable and regulated gene expression system for gene therapy"
                    },
                    "investigators": {
                        "ja": [
                            {
                                "name": "早川 堯夫"
                            },
                            {
                                "name": "水口 裕之"
                            }
                        ],
                        "en": [
                            {
                                "name": "HAYAKAWA Takao"
                            },
                            {
                                "name": "MIZUGUCHI Hiroyuki"
                            }
                        ]
                    },
                    "offer_organization": {
                        "ja": "日本学術振興会",
                        "en": "Japan Society for the Promotion of Science"
                    },
                    "system_name": {
                        "ja": "科学研究費助成事業",
                        "en": "Grants-in-Aid for Scientific Research"
                    },
                    "category": {
                        "ja": "基盤研究(C)",
                        "en": "Grant-in-Aid for Scientific Research (C)"
                    },
                    "institution_name": {
                        "ja": "国立医薬品食品衛生研究所",
                        "en": "National Institute of Health Sciences"
                    },
                    "from_date": "2000",
                    "to_date": "2001",
                    "overall_grant_amount": {
                        "total_cost": "3400000",
                        "direct_cost": "3400000"
                    },
                    "description": {
                        "ja": "遺伝子治療が21世紀の革新的医療技術と位置づけられることは、ゲノム解析の進展とその成果の応用ともあいまって明らかである。この遺伝子治療を普遍的なものとしていくためには、目的遺伝子を必要な細胞に効率よく導入し、遺伝子発現を必要な期間、必要な程度に発現させることができ、かつ安全性も高いベクターおよび遺伝子発現系の開発が必要不可欠である。本研究では、アデノ随伴ウイルス(AAV)がヒト染色体の安全な領域へ部位特異的に遺伝子を組み込む能力を有することに着目し、その機能を担う特定の塩基配列を利用することによる目的遺伝子及び遺伝子発現調節領域の染色体への導入と長期遺伝子発現系の構築に関する技術開発を目指して以下の結果を得た。\n1.AAV ITR配列をもったベクターを、AAV由来の染色体への部位特異的挿入活性を担うRep78発現プラスミドとコ・トランスフェクションすることによりRep78発現プラスミド非存在下の時に比べ薬剤耐性細胞の増加、即ち、染色体への組み込み能の上昇が観察されることを確認した。\n2.ラムダファージに組み込まれたhAATゲノムDNA(19Kb)のプラスミドベクターへのクローニングを試みたが遺伝子サイズが巨大なため通常の方法ではクローニングが困難であった。そこで、大腸菌の相同組換え法を用いてhAATゲノムDNAのプラスミドベクターへの組み込みを検討中である。上記ベクターを作製後、AAV由来の配列を付与し、細胞ヘトランスフェクション後の遺伝子発現制御能、染色体への組み込み能について検討予定である。\n3.効率の良い発現能を有するベクターの開発のため、プロモーター、エンハンサー、イントロン、P(A)からなる転写活性化因子の組み合わせを最適化した。",
                        "en": "In basic genetic research, control oftransgene expression in mammalian cells should be desirable forgene therapyand the studyofgene function. Permanentand higher levels of gene expression should be also preferable. The expression levels of the introduced gene depend mostly on the strength oftranscriptional regulatory elements and the transduction efficiency of the gene transfer vector.\nIn this study, we investigated the effective combination of commonly-used regulatory elements, such as the promoter/enhancer, intron, and polyadenylation signal (P(A)) sequence by constructing a series of plasmids and recombinant adenovirus vectors that differed only in the particular sequence element being evaluated. Of the several promoter/enhancers that were tested, hybrid CA promoter/enhancer containing human cytomegalovirus immediate-early 1 gene (CMV) enhancer and chicken β-actin promoterwith the β-actin intron sequence, and the improved CMV promoter/enhancer containing the largest intron of CMV(intron A) produced the highest levels of expression both in vitro and in vivo. P(A)sequences were found to have significant effects on transgene expression. These comparative analyses could provide a systematic reference for the development of vector construction for gene therapy, vaccine development, and gene transfer experiments.\nNext, we examined the stable gene expression using the plasmids containing the components derived from adeno-associated virus (AAV). We examined the efficiency of colony formation of the neomycin resistant cells which were transfected with the plasmid containing neomycin resistant gene franked with AAVITR (inverted terminal repeat). Number of colony of neomycin resistant cells transfected with the plasmid with AAVITR and Rep78(AAVderived proteinj-expressing plasmid was much higher than that with the plasmid without AAVITRand Rep78expressing plasmid, suggesting that Rep78 protein assisted the integration of the foreing gene intothe host genome. We are now applying this techiniqes intothe integration of the genomic foreign DNA into the host genome. This system using genomic DNA could get stable and regulated gene expression."
                    },
                    "identifiers": {
                        "grant_number": [
                            "12672145"
                        ],
                        "national_grant_number": [
                            "JP12672145"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "kaken",
                            "@id": "https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-12672145"
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/1619/research_projects/44759943",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/1619/research_projects",
                    "rm:id": "44759943",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_internal_feeds",
                    "rm:creator_type": "ai",
                    "rm:created": "2024-01-30T08:24:12Z",
                    "rm:modifier_id": "ai:assign_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2024-01-30T08:24:12Z",
                    "research_project_title": {
                        "ja": "細胞内カルシウムスパーク現象の分子メカニズムの研究"
                    },
                    "investigators": {
                        "ja": [
                            {
                                "name": "川西 徹"
                            },
                            {
                                "name": "重信 弘毅"
                            },
                            {
                                "name": "早川 堯夫"
                            }
                        ]
                    },
                    "offer_organization": {
                        "ja": "日本学術振興会"
                    },
                    "system_name": {
                        "ja": "科学研究費助成事業"
                    },
                    "category": {
                        "ja": "基盤研究(C)"
                    },
                    "institution_name": {
                        "ja": "国立衛生試験所"
                    },
                    "from_date": "1996",
                    "to_date": "1996",
                    "description": {
                        "ja": "ラットあるいはモルモットの単離心室筋細胞にカルシウム蛍光プローブfluo-3を取り込ませ、高速走査型共焦点レーザー顕微鏡でビデオレイト(30画像/秒)で細胞内カルシウムイオンを画像化すると、多くの細胞の細胞質領域で、静止状態にもかかわらずノイズ状の小さな上昇が検出された。そこで顕微鏡の走査領域を1/8に絞り、時間分解能を8倍高めて画像取得すると(バンドスキャン)、この小さな上昇はノイズではなくカルシウムイオン濃度上昇であることが明らかとなった。即ち上昇は直径約2μmの領域で生じ、約10msecでピークに達し、30〜40msecで静止レベルまでもどる小さな領域の極めて速い上昇であることが画像化され、いわゆるカルシウムスパークであることが明らかとなった。スパークは細胞質領域全域にわたってランダムに生じ、蛍光強度の上昇の程度は一つ一つのスパークで異なるものの、時間経過はほとんど同じであった。このカルシウムスパークは、細胞をカルシウムアンタゴニストのニカルジピン3.0μM等で処置しても、頻度および時間的空間的パターンとも変化はなかった。一方、ライアノジン1.0μMを処置すると、消失した。さらにイソプロテレノール1.0μM処置では頻度はほとんど変化しなかったが、上昇の幅が大きくなり、同様な効果は10μMのフォルスコリン処置でも観察された。これらの結果から、(1)スパークは細胞内カルシウムイオン貯蔵部位からの一定単位のカルシウムイオン放出現象である、(2)この放出は細胞内サイクリックAMPの上昇によって増強されうる、ということが示唆された。続いて、画像取得にあたって走査をX軸方向のみにして(ラインスキャン)、時間分解能を約70μsecにして画像を得た。ラインスキャンで画像取得すると、約4msecの時間分解能のバンドスキャンによる画像化では困難であった電気刺激によるカルシウムイオン上昇(スパイク)の立ち上がり相の解析が可能となる。画像化されたスパイクをみると、細胞を長軸方向に走査した場合、細胞全体にわたって約2μmの周期的間隔でカルシウムイオン濃度上昇が生じている様子が上昇の立ち上がり相からみてとれ、さらに直前に比較的上昇の大きなカルシウムスパークが生じている部位では、上昇が遅れて生じることが明らかとなった。この結果から、スパーク現象が、生理的な興奮収縮連関におけるカルシウムイオン濃度上昇の一単位をなすことが示唆された。ちなみに、肝細胞、平滑筋細胞、海馬細胞等では、このような速いスパーク状のカルシウムイオンの上昇は観察されなかった。"
                    },
                    "identifiers": {
                        "grant_number": [
                            "08670131"
                        ],
                        "national_grant_number": [
                            "JP08670131"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "kaken",
                            "@id": "https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-08670131"
                        }
                    ]
                },
                {
                    "@id": "https://api.researchmap.jp/1619/research_projects/44703399",
                    "@type": "research_projects",
                    "@reverse": "https://api.researchmap.jp/1619/research_projects",
                    "rm:id": "44703399",
                    "rm:user_id": "0000041130",
                    "display": "disclosed",
                    "major_achievement": false,
                    "rm:creator_id": "ai:assign_based_internal_feeds",
                    "rm:creator_type": "ai",
                    "rm:created": "2024-01-30T07:25:50Z",
                    "rm:modifier_id": "ai:assign_based_internal_feeds",
                    "rm:modifier_type": "ai",
                    "rm:modified": "2024-01-30T07:25:50Z",
                    "research_project_title": {
                        "ja": "高速走査型共焦点レーザー顕微鏡を用いたカルシウムウェーブの分子メカニズムの研究",
                        "en": "Study on molecular Mechanism of Calcium Waves Using Rapid Scanning Confocal Microscopy"
                    },
                    "investigators": {
                        "ja": [
                            {
                                "name": "川西 徹"
                            },
                            {
                                "name": "早川 尭夫"
                            },
                            {
                                "name": "横田 椅江"
                            },
                            {
                                "name": "太田 美矢子"
                            },
                            {
                                "name": "高橋 道人"
                            },
                            {
                                "name": "豊田 和弘"
                            },
                            {
                                "name": "畝山 智香子"
                            }
                        ],
                        "en": [
                            {
                                "name": "KAWANISHI Toru"
                            },
                            {
                                "name": "HAYAKAWA Takao"
                            },
                            {
                                "name": "YOKOTA Isue"
                            },
                            {
                                "name": "OHTA Miyako"
                            },
                            {
                                "name": "TAKAHASHI Michito"
                            },
                            {
                                "name": "TOYODA Kazuhiro"
                            }
                        ]
                    },
                    "offer_organization": {
                        "ja": "日本学術振興会",
                        "en": "Japan Society for the Promotion of Science"
                    },
                    "system_name": {
                        "ja": "科学研究費助成事業",
                        "en": "Grants-in-Aid for Scientific Research"
                    },
                    "category": {
                        "ja": "一般研究(C)",
                        "en": "Grant-in-Aid for General Scientific Research (C)"
                    },
                    "institution_name": {
                        "ja": "国立衛生試験所",
                        "en": "National Institute of Health Sciences"
                    },
                    "from_date": "1994",
                    "to_date": "1995",
                    "overall_grant_amount": {
                        "total_cost": "2100000",
                        "direct_cost": "2100000"
                    },
                    "description": {
                        "ja": "高速走査型共焦点レーザー顕微鏡を用いて、初代培養肝細胞のカルシウムウェーブ現象のメカニズムを解析した。肝細胞ではフェニレフリン、バソプレシン等によるホルモン性刺激、肝細胞増殖因子(HGF)刺激によって細胞内遊離カルシウムイオン濃度が上昇するが、indo-1と高速走査型共焦点レーザー顕微鏡を用いて画像化してみると、カルシウムイオンの上昇は細胞膜近辺の特定の領域から始まり、細胞を横切るように数秒で上昇が細胞全体にウェーブ状に広がった。さらにIP_3生成を促すことによりカルシウムイオン上昇を引き起こすアゴニストの場合、細胞が同じであれば、アゴニストが異なってもほとんどの細胞では同じパターンのウェーブが生じた。一方、細胞個々のアゴニスト感受性の指標となるカルシウムウェーブが生じるまでの時間は、アゴニスト間で相関は見られなかった。ウェーブのパターンを決定するメカニズムとして、(1)IP_3の局所的生成およびその拡散、(2)細胞内カルシウムイオン貯蔵部位からのカルシウムイオンの放出の伝播、の二つの可能性がある。そこで(1)の可能性を検討するためにHGF受容体を抗受容体抗体を用いて蛍光染色しカルシウムウェーブのパターンと比較したが、相関はみられず、細胞内各部位のカルシウムイオン濃度の速度論的解析によってもIP_3の局所的生成を否定する結果を得た。したがって、ウェーブのパターンは(2)によって決定されているものと考えられた。一方、反応性の高い細胞は一般にウェーブの伝播も速く、かつカルシウムイオンは低濃度から急速に上昇する傾向にあり、細胞の反応性はIP_3の生成量によって決定されていることが示唆された。\n次に細胞内カルシウムイオン放出メカニズムに関わる因子の細胞内分布を調べた。現在までにチュブリン,ミトコンドリア,小胞体、小胞体内のカルシウムイオン結合蛋白質カルレティキュリンを染色してこれらの細胞内分布とウェーブのパターンとを比較したが、相関は無かった。",
                        "en": "The mechanism of calcium waves was analyzed in primary cultured rat hepatocytes using rapid scanning confocal microscopy. Hormonal stimulations by phenylephrine, vasopressin and ATP and a proliferative stimulation by HGF induced repetitive increases of cytosolic free Ca^<2+> concentration ([Ca^<2+>] i). The increases in [Ca^<2+>] i originated from a specific same origin adjacent to the cell membrane and propagated across the cell like waves. In each cell the locus where the Ca^<2+> waves induced by an agonist wre originated was the same as those where the Ca^<2+> waves induced by the other agonists were originated. There was also a correlation in the peak height in the Ca^<2+> weaves induced by different agonists in each cell. However, there was no correlation between sensitivity of each cell to the agonists, which were measured as latent periods prior to Ca^<2+> rises after an addition of the agonists. The kinetic analysis of Ca^<2+> transients in several small regions in the cells suggested the followings : (1) the spatial patterns of Ca^<2+> waves were not depending on the increases of inostiol 1,4,5 triphosphate (Ins (1,4,5) P_3) in the limited parts of the cells and its propagation, but on the distribution of Ins (1,4,5) P_3-sensitive Ca^<2+> pools ; (2) the sensitivity of each cell to agonists was highly depending on the concentration of Ins (1,4,5) P_3 formed."
                    },
                    "identifiers": {
                        "grant_number": [
                            "06670131"
                        ],
                        "national_grant_number": [
                            "JP06670131"
                        ]
                    },
                    "see_also": [
                        {
                            "label": "kaken",
                            "@id": "https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-06670131"
                        }
                    ]
                }
            ]
        }
    ]
}